Amneal Pharmaceuticals (AMRX) Cash from Operations (2017 - 2026)
Amneal Pharmaceuticals (AMRX) posted Cash from Operations of -$21.2 million for Q2 2026, up 20.56% on a QoQ basis from -$26.7 million in Q1 2026, and down 125.35% year-over-year from $83.8 million in Q2 2025.
Powered by 
Analysis
Amneal Pharmaceuticals (AMRX) Cash from Operations (2017 - 2026) Analysis & Trends
Amneal Pharmaceuticals has reported Cash from Operations for 10 years, with the latest figure at -$21.2 million in Q2 2026.
- On a quarterly basis, Cash from Operations fell 125.35% year-over-year to -$21.2 million in Q2 2026; TTM through Jun 2026 was $200.8 million, a 42.81% decrease from a year earlier, with the FY2025 full-year figure at $340.0 million, up 15.21% from the prior year.
- Cash from Operations was -$21.2 million for Q2 2026 at Amneal Pharmaceuticals, up from -$26.7 million in the prior quarter.
- The five-year high for Cash from Operations was $141.8 million in Q3 2024, with the low at -$125.5 million in Q2 2022.
- Average Cash from Operations over 5 years is $55.4 million, with a median of $82.6 million recorded in 2023.
- The sharpest annual moves came in 2023 and 2026: Cash from Operations surged 683.13% in 2023, then plunged 461.0% in 2026.
- Over 5 years, Cash from Operations stood at -$23.3 million in 2022, then soared by 683.13% to $135.8 million in 2023, then declined by 13.06% to $118.1 million in 2024, then rose by 10.36% to $130.3 million in 2025, then tumbled by 116.3% to -$21.2 million in 2026.
- The last three Cash from Operations figures came in at -$21.2 million (Q2 2026), -$26.7 million (Q1 2026), and $130.3 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 46.72 Bn | 43.07 Bn | 2.15 Bn | 411.00 Mn |
| 2 | Viatris | 19.64 Bn | 18.75 Bn | 1.46 Bn | 381.80 Mn |
| 3 | Dr Reddys Laboratories | 10.36 Bn | 10.22 Bn | 396.53 Mn | -9.79 Mn |
| 4 | Amneal Pharmaceuticals | 6.44 Bn | 6.39 Bn | 334.51 Mn | -21.24 Mn |
| 5 | Bausch Health Companies | 2.11 Bn | 1.24 Bn | 2.10 Bn | 670.00 Mn |
| 6 | Ani Pharmaceuticals | 1.88 Bn | 1.52 Bn | 165.89 Mn | 56.67 Mn |
| 7 | Alvotech | 1.83 Bn | 1.69 Bn | 2.56 Mn | -19.79 Mn |
| 8 | Amphastar Pharmaceuticals | 1.04 Bn | 751.07 Mn | 93.47 Mn | 51.32 Mn |
| 9 | Fennec Pharmaceuticals | 382.22 Mn | 340.97 Mn | 17.15 Mn | - |
| 10 | NutriBand | 94.45 Mn | 91.03 Mn | 181,874.00 | -584,999.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -21.24 Mn |
| Mar 31, 2026 | -26.74 Mn |
| Dec 31, 2025 | 130.32 Mn |
| Sep 30, 2025 | 118.45 Mn |
| Jun 30, 2025 | 83.82 Mn |
| Mar 31, 2025 | 7.41 Mn |
| Dec 31, 2024 | 118.08 Mn |
| Sep 30, 2024 | 141.77 Mn |
| Jun 30, 2024 | 39.66 Mn |
| Mar 31, 2024 | -4.41 Mn |
| Dec 31, 2023 | 135.82 Mn |
| Sep 30, 2023 | 81.39 Mn |
| Jun 30, 2023 | -11.35 Mn |
| Mar 31, 2023 | 139.71 Mn |
| Dec 31, 2022 | -23.29 Mn |
| Sep 30, 2022 | 93.57 Mn |
| Jun 30, 2022 | -125.52 Mn |
| Mar 31, 2022 | 120.34 Mn |
| Dec 31, 2021 | 63.26 Mn |
| Sep 30, 2021 | 82.36 Mn |
API Access
Amneal Pharmaceuticals Cash from Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-operations&ticker=AMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-operations", "ticker": "AMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-operations&ticker=AMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();